Another mechanism is associated with oncogenic signaling; the loss of the phosphatase and tensin homolog (PTEN) function has been reported to upregulate PD-L1 expression in glioma and triple-negative breast cancer cells [39,40]. This evidence concerns the gene PTEN and triple-negative breast carcinoma.